Network meta-analysis on patent foramen ovale: is a stroke or atrial fibrillation worse?

go back to reference Mojadidi MK, Elgendy AY, Elgendy IY, Mahmoud AN, Elbadawi A, Eshtehardi P, Patel NK, Wayangankar S, Tobis JM, Meier B (2017) Transcatheter patent foramen ovale closure after cryptogenic stroke: an updated meta-analysis of randomized trials. JACC Cardiovasc Interv 10:2228–2230. https://doi.org/10.1016/j.jcin.2017.09.002CrossRefPubMed Mojadidi MK, Elgendy AY, Elgendy IY, Mahmoud AN, Elbadawi A, Eshtehardi P, Patel NK, Wayangankar S, Tobis JM, Meier B (2017) Transcatheter patent foramen ovale closure after cryptogenic stroke: an updated meta-analysis of randomized trials. JACC Cardiovasc Interv 10:2228–2230. https://​doi.​org/​10.​1016/​j.​jcin.​2017.​09.​002CrossRefPubMed

go back to reference Mojadidi MK, Zaman MO, Elgendy IY, Mahmoud AN, Patel NK, Agarwal N, Tobis JM, Meier B (2018) Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol 71:1035–1043. https://doi.org/10.1016/j.jacc.2017.12.059CrossRefPubMed Mojadidi MK, Zaman MO, Elgendy IY, Mahmoud AN, Patel NK, Agarwal N, Tobis JM, Meier B (2018) Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol 71:1035–1043. https://​doi.​org/​10.​1016/​j.​jacc.​2017.​12.​059CrossRefPubMed

go back to reference Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Guérin P, Piot C, Rossi R, Dubois-Randé JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G, Investigators CLOSE (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. CLOSE Investigators. N Engl J Med 377:1011–1021. https://doi.org/10.1056/NEJMoa1705915CrossRefPubMed Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Guérin P, Piot C, Rossi R, Dubois-Randé JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G, Investigators CLOSE (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. CLOSE Investigators. N Engl J Med 377:1011–1021. https://​doi.​org/​10.​1056/​NEJMoa1705915CrossRefPubMed

go back to reference Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L, Gore REDUCE Clinical Study Investigators (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. Gore REDUCE Clinical Study Investigators. N Engl J Med 377:1033–1042. https://doi.org/10.1056/NEJMoa1707404CrossRefPubMed Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L, Gore REDUCE Clinical Study Investigators (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. Gore REDUCE Clinical Study Investigators. N Engl J Med 377:1033–1042. https://​doi.​org/​10.​1056/​NEJMoa1707404CrossRefPubMed

go back to reference Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, Trelle S, Windecker S, Meier B, Jüni P (2015) Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J 36:120–128. https://doi.org/10.1093/eurheartj/ehu292CrossRefPubMed Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, Trelle S, Windecker S, Meier B, Jüni P (2015) Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J 36:120–128. https://​doi.​org/​10.​1093/​eurheartj/​ehu292CrossRefPubMed

go back to reference Staubach S, Steinberg DH, Zimmermann W, Wawra N, Wilson N, Wunderlich N, Sievert H (2009) New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv 74:889–895. https://doi.org/10.1002/ccd.22172CrossRefPubMed Staubach S, Steinberg DH, Zimmermann W, Wawra N, Wilson N, Wunderlich N, Sievert H (2009) New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv 74:889–895. https://​doi.​org/​10.​1002/​ccd.​22172CrossRefPubMed

go back to reference Elgendy AY, Elgendy IY, Mojadidi MK, Mahmoud AN, Barry JS, Jneid H, Wayangankar SA, Tobis JM, Meier B (2019) New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials. EuroIntervention 14:1788–1790. https://doi.org/10.4244/EIJ-D-18-00767CrossRefPubMed Elgendy AY, Elgendy IY, Mojadidi MK, Mahmoud AN, Barry JS, Jneid H, Wayangankar SA, Tobis JM, Meier B (2019) New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials. EuroIntervention 14:1788–1790. https://​doi.​org/​10.​4244/​EIJ-D-18-00767CrossRefPubMed

go back to reference Taaffe M, Fischer E, Baranowski A, Majunke N, Heinisch C, Leetz M, Hein R, Bayard Y, Büscheck F, Reschke M, Hoffmann I, Wunderlich N, Wilson N, Sievert H (2018) Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol 101:1353–1358. https://doi.org/10.1016/j.amjcard.2007.12.040CrossRef Taaffe M, Fischer E, Baranowski A, Majunke N, Heinisch C, Leetz M, Hein R, Bayard Y, Büscheck F, Reschke M, Hoffmann I, Wunderlich N, Wilson N, Sievert H (2018) Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol 101:1353–1358. https://​doi.​org/​10.​1016/​j.​amjcard.​2007.​12.​040CrossRef

go back to reference Turc G, Calvet D, Guérin P, Sroussi M, Chatellier G, Mas JL, CLOSE Investigators (2018) Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE Study. J Am Heart Assoc 7:e008356. https://doi.org/10.1161/JAHA.117.008356CrossRefPubMedPubMedCentral Turc G, Calvet D, Guérin P, Sroussi M, Chatellier G, Mas JL, CLOSE Investigators (2018) Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE Study. J Am Heart Assoc 7:e008356. https://​doi.​org/​10.​1161/​JAHA.​117.​008356CrossRefPubMedPubMedCentral

go back to reference Madhkour R, Wahl A, Praz F, Maier B (2019) Amplatzer patent foramen ovale occluder: safety and efficacy. Expert Rev Med Devices 16:173–182. https://doi.org/10.1080/17434440.2019.1581060CrossRefPubMed Madhkour R, Wahl A, Praz F, Maier B (2019) Amplatzer patent foramen ovale occluder: safety and efficacy. Expert Rev Med Devices 16:173–182. https://​doi.​org/​10.​1080/​17434440.​2019.​1581060CrossRefPubMed

go back to reference Hornung M, Bertog SC, Franke J, Id D, Taaffe M, Wunderlich N, Vaskelyte L, Hofmann I, Sievert H (2013) Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale. Eur Heart J 34:3362–3369. https://doi.org/10.1093/eurheartj/eht283CrossRefPubMed Hornung M, Bertog SC, Franke J, Id D, Taaffe M, Wunderlich N, Vaskelyte L, Hofmann I, Sievert H (2013) Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale. Eur Heart J 34:3362–3369. https://​doi.​org/​10.​1093/​eurheartj/​eht283CrossRefPubMed

go back to reference Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L, CLOSURE I Investigators (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366:991–999. https://doi.org/10.1056/NEJMoa1009639CrossRefPubMed Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L, CLOSURE I Investigators (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366:991–999. https://​doi.​org/​10.​1056/​NEJMoa1009639CrossRefPubMed

go back to reference Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P, Trial Investigators PC (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 368:1083–1091. https://doi.org/10.1056/NEJMoa1211716CrossRefPubMed Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P, Trial Investigators PC (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 368:1083–1091. https://​doi.​org/​10.​1056/​NEJMoa1211716CrossRefPubMed

go back to reference Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092–1100. https://doi.org/10.1056/NEJMoa1301440CrossRefPubMed Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092–1100. https://​doi.​org/​10.​1056/​NEJMoa1301440CrossRefPubMed

go back to reference Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 377:1022–1032. https://doi.org/10.1056/NEJMoa1610057CrossRefPubMed Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 377:1022–1032. https://​doi.​org/​10.​1056/​NEJMoa1610057CrossRefPubMed

go back to reference Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, Song JM, Kang DH, Kwon SU, Kang DW, Lee D, Kwon HS, Yun SC, Sun BJ, Park JH, Lee JH, Jeong HS, Song HJ, Kim J, Park SJ (2018) Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO Trial. J Am Coll Cardiol 71:2335–2342. https://doi.org/10.1016/j.jacc.2018.02.046CrossRefPubMed Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, Song JM, Kang DH, Kwon SU, Kang DW, Lee D, Kwon HS, Yun SC, Sun BJ, Park JH, Lee JH, Jeong HS, Song HJ, Kim J, Park SJ (2018) Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO Trial. J Am Coll Cardiol 71:2335–2342. https://​doi.​org/​10.​1016/​j.​jacc.​2018.​02.​046CrossRefPubMed

go back to reference Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1. https://doi.org/10.1186/2046-4053-4-1CrossRefPubMedPubMedCentral Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1. https://​doi.​org/​10.​1186/​2046-4053-4-1CrossRefPubMedPubMedCentral

go back to reference Jüni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323:42–46. https://doi.org/10.1136/bmj.323.7303.42CrossRefPubMedPubMedCentral Jüni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323:42–46. https://​doi.​org/​10.​1136/​bmj.​323.​7303.​42CrossRefPubMedPubMedCentral

go back to reference Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JP, Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JA (2012) Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 157:429–438. https://doi.org/10.7326/0003-4819-157-6-201209180-00537CrossRefPubMed Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JP, Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JA (2012) Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 157:429–438. https://​doi.​org/​10.​7326/​0003-4819-157-6-201209180-00537CrossRefPubMed

go back to reference Page MJ, Higgins JP, Clayton G, Sterne JA, Hróbjartsson A, Savović J (2016) Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies. PLoS One 11:e0159267. https://doi.org/10.1371/journal.pone.0159267CrossRefPubMedPubMedCentral Page MJ, Higgins JP, Clayton G, Sterne JA, Hróbjartsson A, Savović J (2016) Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies. PLoS One 11:e0159267. https://​doi.​org/​10.​1371/​journal.​pone.​0159267CrossRefPubMedPubMedCentral

go back to reference Higgins JP, Altman DG, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928CrossRefPubMedPubMedCentral Higgins JP, Altman DG, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://​doi.​org/​10.​1136/​bmj.​d5928CrossRefPubMedPubMedCentral

go back to reference Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparison. Stat Med 23:3105–3124. https://doi.org/10.1002/sim.1875CrossRefPubMed Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparison. Stat Med 23:3105–3124. https://​doi.​org/​10.​1002/​sim.​1875CrossRefPubMed

go back to reference Brown S, Hutton B, Clifford T, Coyle D, Grima D, Wells G, Cameron C (2014) A Microsoft-Excel-based tool for running and critically appraising network meta-analyses--an overview and application of NetMetaXL. Syst Rev 3:110. https://doi.org/10.1186/2046-4053-3-110CrossRefPubMedPubMedCentral Brown S, Hutton B, Clifford T, Coyle D, Grima D, Wells G, Cameron C (2014) A Microsoft-Excel-based tool for running and critically appraising network meta-analyses--an overview and application of NetMetaXL. Syst Rev 3:110. https://​doi.​org/​10.​1186/​2046-4053-3-110CrossRefPubMedPubMedCentral

go back to reference Straus SE (2002) Individualizing treatment decisions. The likelihood of being helped or harmed. Eval Health Prof 25:210–224. https://doi.org/10.1177/016327870202500206CrossRefPubMed Straus SE (2002) Individualizing treatment decisions. The likelihood of being helped or harmed. Eval Health Prof 25:210–224. https://​doi.​org/​10.​1177/​0163278702025002​06CrossRefPubMed

go back to reference Jarral OA, Sao A, Vecht JA, Harling L, Rao C, Ahmed K, Gatzoulis MA, Malik IS, Athanasiou T (2011) Does patent foramen ovale closure have an anti-arrhythmic effect? A meta-analysis. Int J Cardiol 153:4–9. https://doi.org/10.1016/j.ijcard.2011.02.027CrossRefPubMed Jarral OA, Sao A, Vecht JA, Harling L, Rao C, Ahmed K, Gatzoulis MA, Malik IS, Athanasiou T (2011) Does patent foramen ovale closure have an anti-arrhythmic effect? A meta-analysis. Int J Cardiol 153:4–9. https://​doi.​org/​10.​1016/​j.​ijcard.​2011.​02.​027CrossRefPubMed

go back to reference Berthet K, Lavergne T, Cohen A, Guize L, Bousser MG, Le Heuzey JY, Amarenco P (2000) Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 31:398–403. https://doi.org/10.1161/01.str.31.2.398CrossRefPubMed Berthet K, Lavergne T, Cohen A, Guize L, Bousser MG, Le Heuzey JY, Amarenco P (2000) Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 31:398–403. https://​doi.​org/​10.​1161/​01.​str.​31.​2.​398CrossRefPubMed

go back to reference Allessie MA, Boyden PA, Camm AJ, Kléber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR, Waldo AL (2001) Pathophysiology and prevention of atrial fibrillation. Circulation 103:769–777. https://doi.org/10.1161/01.cir.103.5.769CrossRefPubMed Allessie MA, Boyden PA, Camm AJ, Kléber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR, Waldo AL (2001) Pathophysiology and prevention of atrial fibrillation. Circulation 103:769–777. https://​doi.​org/​10.​1161/​01.​cir.​103.​5.​769CrossRefPubMed

go back to reference Franz MR (2000) Mechano-electrical feedback. Cardiovasc Res 45:263–266. https://doi.org/10.1016/s0008-6363(99)00390-9CrossRefPubMed Franz MR (2000) Mechano-electrical feedback. Cardiovasc Res 45:263–266. https://​doi.​org/​10.​1016/​s0008-6363(99)00390-9CrossRefPubMed

go back to reference Pristipino C, Sievert H, D’Ascenzo F, Mas JL, Meier B, Scacciatella P, Hildick-Smith D, Gaita F, Toni D, Kyrle P, Thomson J, Derumeaux G, Onorato E, Sibbing D, Germonpré P, Berti S, Chessa M, Bedogni F, Dudek D, Hornung M, Zamorano J, European Association of Percutaneous Cardiovascular Interventions (EAPCI); European Stroke Organisation (ESO); European Heart Rhythm Association (EHRA); European Association for Cardiovascular Imaging (EACVI); Association for European Paediatric and Congenital Cardiology (AEPC); ESC Working group on GUCH; ESC Working group on Thrombosis; European Haematological Society (EHA) (2019) European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. EuroIntervention 14:1389–1402. https://doi.org/10.4244/EIJ-D-18-00622CrossRefPubMed Pristipino C, Sievert H, D’Ascenzo F, Mas JL, Meier B, Scacciatella P, Hildick-Smith D, Gaita F, Toni D, Kyrle P, Thomson J, Derumeaux G, Onorato E, Sibbing D, Germonpré P, Berti S, Chessa M, Bedogni F, Dudek D, Hornung M, Zamorano J, European Association of Percutaneous Cardiovascular Interventions (EAPCI); European Stroke Organisation (ESO); European Heart Rhythm Association (EHRA); European Association for Cardiovascular Imaging (EACVI); Association for European Paediatric and Congenital Cardiology (AEPC); ESC Working group on GUCH; ESC Working group on Thrombosis; European Haematological Society (EHA) (2019) European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. EuroIntervention 14:1389–1402. https://​doi.​org/​10.​4244/​EIJ-D-18-00622CrossRefPubMed

go back to reference Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J, CRYSTAL AF Investigators (2014) Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370:2478–2486. https://doi.org/10.1056/NEJMoa1313600CrossRefPubMed Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J, CRYSTAL AF Investigators (2014) Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370:2478–2486. https://​doi.​org/​10.​1056/​NEJMoa1313600CrossRefPubMed

go back to reference Tung CE, Derek Su D, Turakhia MP, Lansberg MG (2015) Diagnostic yield of extended cardiac patch monitoring in patients with stroke or TIA. Front Neurol 5:266. https://doi.org/10.3389/fneur.2014.00266CrossRefPubMedPubMedCentral Tung CE, Derek Su D, Turakhia MP, Lansberg MG (2015) Diagnostic yield of extended cardiac patch monitoring in patients with stroke or TIA. Front Neurol 5:266. https://​doi.​org/​10.​3389/​fneur.​2014.​00266CrossRefPubMedPubMedCentral